A Novel Preclinical In Vitro 3D Model of Oral Carcinogenesis for Biomarker Discovery and Drug Testing
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24044096 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ravi Teja Chitturi Suryaprakash und 8 weiteren Autor:innen. Beteiligte Einrichtung: UWA Dental School, The University of Western Australia, Nedlands, WA 6009, Australia. Hauptthemen laut MEDLINE: Carcinogenesis, Mouth Neoplasms, Cell Culture Techniques, Three Dimensional, Biomarkers, Tumor. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Western Australia Department of Health, Future Health Research and Innovation Fund scheme, Australian Dental Research Foundation.
Abstract (Originalsprache)
This study aimed to develop an in vitro three-dimensional (3D) cell culture model of oral carcinogenesis for the rapid, scalable testing of chemotherapeutic agents. Spheroids of normal (HOK) and dysplastic (DOK) human oral keratinocytes were cultured and treated with 4-nitroquinoline-1-oxide (4NQO). A 3D invasion assay using Matrigel was performed to validate the model. RNA was extracted and subjected to transcriptomic analysis to validate the model and assess carcinogen-induced changes. The VEGF inhibitors pazopanib and lenvatinib were tested in the model and were validated by a 3D invasion assay, which demonstrated that changes induced by the carcinogen in spheroids were consistent with a malignant phenotype. Further validation was obtained by bioinformatic analyses, which showed the enrichment of pathways associated with hallmarks of cancer and VEGF signalling. Overexpression of common genes associated with tobacco-induced oral squamous cell carcinoma (OSCC), such as MMP1, MMP3, MMP9, YAP1, CYP1A1, and CYP1B1, was also observed. Pazopanib and lenvatinib inhibited the invasion of transformed spheroids. In summary, we successfully established a 3D spheroid model of oral carcinogenesis for biomarker discovery and drug testing. This model is a validated preclinical model for OSCC development and would be suitable for testing a range of chemotherapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UWA Dental School, The University of Western Australia, Nedlands, WA 6009, Australia.
- Australian Centre for Oral Oncology Research and Education, Nedlands, WA 6009, Australia.
- Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Nedlands, WA 6009, Australia.
- Genomics WA, Harry Perkins Institute of Medical Research, Telethon Kids Institute, The University of Western Australia, Nedlands, WA 6009, Australia.
ORCID-Profile: Camile S Farah, Simon A Fox, Muhammad Munir Iqbal, Alka Saxena, Omar Kujan
Förderung
- Government of Western Australia Department of Health
- Future Health Research and Innovation Fund scheme
- Australian Dental Research Foundation
- University of Western Australia
Zitieren
APA
Chitturi Suryaprakash, R. T., Shearston, K., Farah, C. S., Fox, S. A., Iqbal, M. M., Kadolsky, U., Zhong, X., Saxena, A., & Kujan, O. (2023). A Novel Preclinical In Vitro 3D Model of Oral Carcinogenesis for Biomarker Discovery and Drug Testing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044096
Vancouver
Chitturi Suryaprakash RT, Shearston K, Farah CS, Fox SA, Iqbal MM, Kadolsky U, et al. A Novel Preclinical In Vitro 3D Model of Oral Carcinogenesis for Biomarker Discovery and Drug Testing. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044096
BibTeX
@article{ChitturiSuryaprakash2023,
author = {Chitturi Suryaprakash, Ravi Teja and Shearston, Kate and Farah, Camile S and Fox, Simon A and Iqbal, Muhammad Munir and Kadolsky, Ulrich and Zhong, Xiao and Saxena, Alka and Kujan, Omar},
title = {A Novel Preclinical In Vitro 3D Model of Oral Carcinogenesis for Biomarker Discovery and Drug Testing},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24044096}
}
EUVIMED